Eloxx holders elect all 5 director nominees, ratify auditor, approve say-on-pay

Eloxx Pharmaceuticals, Inc.

All five director nominees elected: Kariv (557,994 for), Aggarwal (511,136), Androski (559,991), Rubin (509,103), Walts (559,951).
Ratification of Baker Tilly as auditor passed with 1,181,736 for, 23,057 against, 48,182 abstain.
Advisory say-on-pay vote approved: 550,254 for, 12,373 against, 42,508 abstain; 647,840 broker non-votes.
Approximately 57.83% of outstanding shares were represented at the meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Eloxx Pharmaceuticals, Inc. shareholders approved Election of five directors to hold office until the 2024 annual meeting at the 2023-06-22 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-22

Exact text from the filing

Proposal 1 - Election of five (5) directors to hold office until the Company’s annual meeting of stockholders to be held in 2024 and until his or her respective successor is duly elected and qualified.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Eloxx Pharmaceuticals, Inc. shareholders approved Advisory vote on the compensation of the Company's named executive officers at the 2023-06-22 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-22

Exact text from the filing

Proposal 3 - Advisory vote on the compensation of the Company’s named executive officers.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Eloxx Pharmaceuticals, Inc. shareholders approved Ratification of the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the year ending December 31, 2023 at the 2023-06-22 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-22

Exact text from the filing

Proposal 2 - Ratification of the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023.

View on SEC.gov

224 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Eloxx Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-073875

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.